Research Driven Drug Discovery
Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics.
Ubiquitin Specific Proteases
Deubiquitinating enzymes (DUBs) and their subset ubiquitin specific proteases (USP’s) hold the promise of producing many new drugs across a wide range of indications.
Protein Drug Conjugates
Antibodies and proteins are a key element of a clinician’s arsenal of therapeutics but they are not perfect. The improvements needed will require notable new technologies. Almac Discovery is exploring drug conjugates as the way forward.
Latest from Almac Discovery
WEE1 Inhibitor discovered by Almac Discovery advanced into two clinical studies addressing the treatment of advanced solid tumours
Almac Discovery and HitGen Announce Strategic Research Collaboration
Professor Daniel Longley Joins Almac Discovery to Accelerate Colorectal Cancer Research
Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Key Research Areas
Almac Discovery specialise in Ubiquitin Specific Proteases (USPs)Read more
Discovery News & Events
Stay up to date with all the latest news and events at Almac Discovery.Read more